Test Price
2,800 AED✅ Home Collection Available
NDUFB3 Gene Mitochondrial Complex I Deficiency Genetic Test in UAE
Executive Summary & Core Metrics
🏆 Diagnostic Confidence: 99.9% Analytical Sensitivity via ISO 9001:2015 Certified NGS Workflow
🚚 Premium Logistics: Complimentary ISO-certified cold-chain home collection (8 AM – 11 PM) with VIP mobile phlebotomy. Samples transported at 2–8°C directly to our DHA-licensed molecular lab.
🧬 Clinical Guidance: Mandatory pre‑ and post‑test genetic counselling included. Telephonic post‑test result interpretation by a clinical geneticist within 72 hours of report release.
💳 Insurance Direct Billing: Verify your policy instantly via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
Clinical Test Overview
This Next‑Generation Sequencing (NGS) assay targets the entire coding region of the NDUFB3 gene to detect pathogenic variants causing mitochondrial Complex I deficiency – a severe neurometabolic disorder. Delivered with a 21-calendar-day turnaround and mandatory genetic counselling, it stands as the most focused, high‑depth diagnostic tool for this specific nuclear gene compared to broader multi‑gene panels.
| Feature | Our NDUFB3 Targeted NGS | Closest Alternative (Whole Exome Sequencing) |
|---|---|---|
| Diagnostic Precision | >99.9% sensitivity for NDUFB3 SNVs/indels, 100% coverage at ≥30× depth | 86% sensitivity for nuclear mitochondrial genes; requires confirmatory testing |
| Methodology | NGS with proprietary long‑range PCR enrichment, verified by Sanger sequencing of all reported variants | Broad exome capture; lower mean depth on mitochondrial nuclear genes |
| Reporting Speed | 21 calendar days from sample receipt (3–4 weeks total) | 6–8 weeks typical; incidental findings delay interpretation |
Physician Insight & Safety Protocols
“A positive NDUFB3 result provides a definitive genetic basis for mitochondrial Complex I deficiency, yet it must always be correlated with functional biochemical assays and neurological examination. I recommend metabolic counseling and family cascade screening when a pathogenic variant is identified. Our team ensures every result is interpreted within the full clinical context.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory – Medication & Clinical Context
⚠️ MEDICATION NOTICE:
Do not discontinue any prescribed medication, especially anti‑epileptics or mitochondrial supplements, without prior consultation with your treating physician. Test results must be reviewed in context of current therapy and may influence, but never solely dictate, treatment changes.
Patient Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: This test is not designed for mitochondrial tRNA or large deletion analysis; suspected mtDNA‑only disorders require a separate mitochondrial genome test.
- Exclusion: Samples hemolyzed, clotted, or received at temperatures >8°C will be rejected; recollection at no extra charge.
- Exclusion: Direct‑to‑consumer ordering by minors without a legal guardian’s consent is prohibited under UAE Child Rights Law (Federal Law No. 3 of 2016).
- Emergency: If the patient develops acute metabolic decompensation (vomiting, lethargy, seizures, hypoglycemia), proceed immediately to the nearest emergency department – do not wait for test results.
- Emergency: A “negative” NDUFB3 report does not rule out other mitochondrial disorders; if clinical suspicion remains high, urgent metabolic specialist consult is mandatory.
Patient FAQ & Clinical Guidance
1. What does a positive NDUFB3 gene test mean for my child’s neurological symptoms?
A positive NDUFB3 result confirms a genetic basis for mitochondrial Complex I deficiency, directly linking to your child’s neurological regression, dystonia, or seizures. Clinical correlation by a DHA‑licensed geneticist is essential to distinguish this finding from other possible mitochondrial or nuclear gene defects, and it guides precise metabolic interventions and prognostic discussions.
2. Is home sample collection safe and reliable for this highly sensitive DNA?
Yes, our FDA‑listed and ISO‑certified cold chain home phlebotomy service ensures DNA integrity from collection to lab; a single EDTA blood tube or FTA card is drawn by a DHA‑licensed nurse and transported at 2–8°C within 6 hours, eliminating pre‑analytical errors that commonly affect NGS results.
3. How will my personal genetic data be protected under UAE law?
All NDUFB3 sequencing data is secured, encrypted, and processed within our on‑shore UAE server, strictly governed by Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL); we never share identifiable genetic information with third parties without your explicit, DHA‑compliant informed consent.
UAE Regulatory & Data Privacy Adherence
Data Protection & Health Information Governance:
- All genetic data processing complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – your genomic information is encrypted and stored exclusively within UAE‑based servers.
- Health information handling follows Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, ensuring secure digital transmission and storage of all clinical records.
- Clinical safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability, guaranteeing that every test is ordered under informed consent and medically supervised.
- DNA Labs UAE is fully licensed by the Dubai Health Authority (DHA) under Facility License Number 1143 and operates in strict compliance with all UAE federal health data regulations.
Clinical & Logistical Metadata
| Test Name | NDUFB3 Gene Mitochondrial Complex I Deficiency Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 21 calendar days (3–4 weeks from sample receipt) |
| Sample Type / Matrix | Peripheral whole blood (EDTA tube or FTA card) |
| Methodology Used | Next‑Generation Sequencing (NGS) with long‑range PCR enrichment, confirmed by Sanger sequencing of all reported variants |
| ICD-10-CM Code | E88.49 |
| LOINC Code | 94265-1 |
| DHA Facility License & Laboratory Address | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DHA License No: 1143 |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians